Minocycline in Stroke Study at Maimonides

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1164 participants.

Also called NCT07237048

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 2/3
Enrolled
  • 1,164 participants (planned count) (from the registry)
Sponsor
Joyce Chen (from the registry)
Registry
  • NCT NCT07237048
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07237048. Randomized; single masking; primary purpose treatment. Start 2026-02-02 (actual); primary completion 2028-12-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Minocycline in Stroke Study at Maimonides
Condition
Stroke
Condition
Ischemia Stroke
Condition
Hemorrhagic Strokes
Condition
Mortality
Condition
Morbidity
Condition
Cerebrovascular Accident (Stroke)
Condition
Intracerebral Haemorrhage (ICH)
Intervention (Drug)
Minocycline 200mg
Lead sponsor
Joyce Chen (class: other)

Record details

Record id
cardio:ct-nct07237048
Content hash
1619687a7ba7b00a688a88fa0a602ca89e90e6022d75ba0497168c3fd6ffb484